This website uses cookies.
Privacy policy   

I SEE

Orthopedics

HYALURONIC ACID

It was isolated about 70 years ago. The name comes from its glassy transparent appearance (from Greek hyalos = glass). It is a colorless, transparent, hygroscopic liquid with the consistency of a thick gel. Half of all hyaluronic acid contained in the human body is found in the skin. As we age, the acid content in the skin decreases significantly, which is one of the reasons why wrinkles appear. Hyaluronic acid produced biotechnologically is a compound valued in cosmetology, because it is based on gels used to fill wrinkles and to produce implants, e.g. for breast enlargement.READ MORE In orthopedics, hyaluronic acid plays an important role in replenishing synovial fluid, improving the mobility of elbow, knee and other joints. After the age of 40, rheumatic pain may occur, limiting mobility. Degenerative changes, injuries, and excessive loads on the joints cause the destruction of articular cartilage. We may also encounter symptoms of joint dysfunction much earlier, e.g. if we practice sports or in specific professional groups exposed to overload, such as: rescuers, professional athletes, miners. Factors that increase the risk of movement limitations include: overweight, injuries and, for example, meniscus surgery. Pain and limited joint mobility are eliminated when additional amounts of hyaluronic acid (1% sodium hyaluronate) are introduced directly into the joint cavity using a needle and syringe. An allergy test is not required before using the first dose. After application, the preparation does not cause allergic reactions such as irritations, allergies, redness or burning. Back

To order a product, go to the Contact tab (or click here). In the form, please provide: Product name and City where you are ordering from. We will soon launch the possibility of ordering directly from this subpage.

BIOVISC ORTHO

Concentration 10 mg/ml (1%) / Volume: 2ml

The preparation is a sterile, viscoelastic solution of hyaluronic acid, used in intra-articular injections in case of pain and/or stiffness of synovial joints. The preparation is recommended for people suffering from: degenerative joint disease, overload, sports-related injuries, as well as for people exposed to micro-injuries.

BIOVISC ORTHO is a sterile, transparent, homogeneous, viscoelastic gel containing hyaluronic acid with a high molecular weight, guaranteeing qualitative replenishment of synovial fluid. BIOVISC ORTHO contains 10 mg/ml hyaluronic acid in a phosphate-buffered saline solution. BIOVISC ORTHO contains hyaluronic acid of biofermentative origin with a purity class suitable for injection, free from animal proteins. BIOVISC ORTHO is available in 2 ml and 3 ml ampoules. It is possible to use BIOVISC ORTHO in several joints at the same time.

Specification:
  • Concentration: 10 mg/ml (1%) sodium hyaluronate
  • Obtaining method:biofermentation
  • Molecular weight: 3.3 million Da
  • Osmolarity:270 – 400 mOsmol/kg
  • pH: 7.2
  • Composition:Sodium hyaluronate, Phosphate-buffered saline
  • Number of injections: 3-5
  • Volume: 2ml

The preparation is a medical device manufactured in accordance with ISO and GMP standards.

The contents of the package include a 2 ml, disposable glass syringe with a Luer-lock connector, packed in a blister. The contents of the syringe are sterile, stabilized, non-animal hyaluronic acid gel. It is recommended to use a needle (18G-25-G) of an appropriate length, adapted to the injection of the gel into a given joint.

BIOVISC ORTHO

Concentration 10 mg/ml (1%) / Volume: 3ml

The preparation is a sterile, viscoelastic solution of hyaluronic acid, used in intra-articular injections in case of pain and/or stiffness of synovial joints. The preparation is recommended for people suffering from: degenerative joint disease, overload, sports-related injuries, as well as for people exposed to micro-injuries.

BIOVISC ORTHO is a sterile, transparent, homogeneous, viscoelastic gel containing hyaluronic acid with a high molecular weight, guaranteeing qualitative replenishment of synovial fluid. BIOVISC ORTHO contains 10 mg/ml hyaluronic acid in a phosphate-buffered saline solution. BIOVISC ORTHO contains hyaluronic acid of biofermentative origin with a purity class suitable for injection, free from animal proteins. BIOVISC ORTHO is available in 2 ml and 3 ml ampoules. It is possible to use BIOVISC ORTHO in several joints at the same time.

Specification:
  • Concentration: 10 mg/ml (1%) sodium hyaluronate
  • Preparation method: biofermentation
  • Molecular weight: 3.3 million Da
  • Osmolarity: 270 – 400 mOsmol/kg
  • pH: 7.2
  • Ingredients: Sodium hyaluronate, Phosphate-buffered saline
  • Number of injections: 3-5
  • Volume: 3ml

The preparation is a medical device manufactured in accordance with ISO and GMP standards.

The contents of the package include a 3 ml, disposable glass syringe with a Luer-lock connector, packed in a blister. The contents of the syringe are sterile, stabilized, non-animal hyaluronic acid gel. It is recommended to use a needle (18G-25-G) of an appropriate length, adapted to the injection of the gel into a given joint.

BIOVISC ORTHO PLUS

Concentration 40 mg/ml (2%) / Volume: 2ml

It is a sterile, viscoelastic solution of hyaluronic acid, used in intra-articular injections in case of pain and/or stiffness of synovial joints. BIOVISC ORTHO PLUS is recommended for people suffering from: degenerative joint disease, overload, sports-related injuries, as well as for people exposed to micro-injuries.

BIOVISC ORTHO PLUS is a sterile, transparent, homogeneous, viscoelastic gel containing hyaluronic acid with a high molecular weight. BIOVISC ORTHO PLUS contains 40 mg/ml hyaluronic acid in a phosphate-buffered saline solution. BIOVISC ORTHO PLUS contains hyaluronic acid of biofermentative origin with a purity class suitable for injection, free from animal proteins. BIOVISC ORTHO PLUS is available in 2 ml ampoules. It is possible to use BIOVISC ORTHO PLUS in several joints at the same time.

Specification:
  • Concentration: 40 mg/ml (2%) sodium hyaluronate
  • Preparation method: biofermentation
  • Molecular weight:
  • pH: 7.2
  • Ingredients: Sodium hyaluronate, Phosphate-buffered saline
  • Number of injections: 1-3
  • Volume: 2 ml

The preparation is a medical device manufactured in accordance with ISO and GMP standards.

The contents of the package include a 2 ml disposable glass syringe with a Luer-lock connector, packed in a blister. The contents of the syringe are sterile, stabilized, non-animal hyaluronic acid gel. It is recommended to use a needle (18G-25-G) of an appropriate length, adapted to the injection of the gel into a given joint.

BIOVISC ORTHO SINGLE

Concentration 30 mg/ml (3%) / Volume: 3ml

The preparation is a sterile, viscoelastic long-acting hyaluronic acid solution, used in intra-articular injections in the case of pain and/or stiffness of synovial joints. The preparation is recommended for people suffering from: degenerative joint disease, overload, sports-related injuries, as well as for people exposed to micro-injuries.

BIOVISC ORTHO SINGLE is a sterile, transparent, homogeneous, viscoelastic gel containing hyaluronic acid with a high molecular weight. BIOVISC ORTHO SINGLE contains 30 mg/ml hyaluronic acid in a phosphate-buffered saline solution. BIOVISC ORTHO SINGLE contains hyaluronic acid of biofermentative origin with a purity class suitable for injection, free from animal proteins, guaranteeing qualitative replenishment of synovial fluid. The hyaluronic acid used in BIOVISC ORTHO SINGLE has a cross-linked structure that changes its rheological properties to more viscous and reduces its solubility, therefore such hyaluronic acid is characterized by a prolonged duration of action and better biocompatibility. BIOVISC ORTHO SINGLE is available in 3 ml ampoules. It is possible to use BIOVISC ORTHO SINGLE in several joints at the same time.

Specification:
  • Concentration: 30 mg/ml (3%) sodium hyaluronate
  • Preparation method: biofermentation
  • Molecular weight: 3.4-3.8 million Da
  • pH: 7.2
  • Ingredients: Sodium hyaluronate, Phosphate-buffered saline
  • Number of injections: 1
  • Volume: 3 ml
  • Crosslinking: YES

The preparation is a medical device manufactured in accordance with ISO and GMP standards.

The contents of the package include a 2 ml/3 ml disposable glass syringe with Luer-lock connector, packed in a blister. The contents of the syringe are sterile, stabilized, non-animal hyaluronic acid gel. It is recommended to use a needle (18G-25-G) of appropriate length, adapted to the injection,

Albomed

Albomed 2.5%

Concentration: 120mg Volume: 4.8ml

This is an intra-articular injection with the highest hyaluronic acid content available on the market. The syringe contains 4.8 ml of gel containing 120 mg of pure hyaluronic acid. KD 2.5% is a product with high clinical effectiveness, produced in Germany, meets the highest safety standards.

Product characteristics:

  • Product with the highest HA content on the market.
  • Only 1 injection
  • Fast and strong pain reduction and long-lasting therapy effect.
  • Viscosity and elasticity imitating the natural parameters of synovial fluid.
  • Excellent cushioning effect thanks to high density.
  • Pure, non-cross-linked HA provides few side effects.
Composition:Sodium hyaluronate, sodium chloride, sodium hydrogen phosphate 2 H2O, sodium dihydrogen phosphate 2 H2O, water for injection

Indications:Pain and limited joint mobility in the case of degenerative and traumatic changes of the knee joint and other synovial joints, including osteoarthritis.

Dosage:1 injection